Literature DB >> 23778875

ATP-sensitive potassium (K(ATP)) channel openers diazoxide and nicorandil lower intraocular pressure in vivo.

Uttio Roy Chowdhury1, Bradley H Holman, Michael P Fautsch.   

Abstract

PURPOSE: To evaluate the expression of ATP-sensitive potassium (K(ATP)) channel subunits and study the effect of K(ATP) channel openers diazoxide and nicorandil on intraocular pressure (IOP) in an in vivo mouse model.
METHODS: Expression of K(ATP) channel subunits in normal C57BL/6 mouse eyes was studied by immunohistochemistry and confocal microscopy. Wild-type C57BL/6 mice were treated with K(ATP) channel openers diazoxide (n = 10) and nicorandil (n = 10) for 14 days. Similar treatments with diazoxide were performed on K(ir)6.2((-/-)) mice (n = 10). IOP was recorded with a handheld tonometer 1 hour, 4 hours, and 23 hours following daily treatment. Posttreatment histology was examined by light and transmission electron microscopy.
RESULTS: The K(ATP) channel subunits SUR2B, K(ir)6.1, and K(ir)6.2 were identified in all tissues within mouse eyes. Treatment with diazoxide in wild-type mice decreased IOP by 21.5 ± 3.2% with an absolute IOP reduction of 3.9 ± 0.6 mm Hg (P = 0.002). Nicorandil also decreased IOP (18.9 ± 1.8%) with an absolute IOP reduction of 3.4 ± 0.4 mm Hg (P = 0.002). Treatment with diazoxide in K(ir)6.2((-/-)) mice had no effect on IOP. No morphological abnormalities were observed in diazoxide- or nicorandil-treated eyes.
CONCLUSIONS: K(ATP) channel openers diazoxide and nicorandil are effective regulators of IOP in mouse eyes. K(ir)6.2 appears to be a major K(ATP) channel subunit through which IOP is lowered following treatment with diazoxide.

Entities:  

Keywords:  anterior segment; intraocular pressure; potassium channel

Mesh:

Substances:

Year:  2013        PMID: 23778875      PMCID: PMC3720149          DOI: 10.1167/iovs.13-11872

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  51 in total

1.  Nucleotide-gated KATP channels integrated with creatine and adenylate kinases: amplification, tuning and sensing of energetic signals in the compartmentalized cellular environment.

Authors:  Vitaliy A Selivanov; Alexey E Alekseev; Denice M Hodgson; Petras P Dzeja; Andre Terzic
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

2.  ATP-sensitive K+ channel knockout compromises the metabolic benefit of exercise training, resulting in cardiac deficits.

Authors:  Garvan C Kane; Atta Behfar; Satsuki Yamada; Carmen Perez-Terzic; Fearghas O'Cochlain; Santiago Reyes; Petras P Dzeja; Takashi Miki; Susumu Seino; Andre Terzic
Journal:  Diabetes       Date:  2004-12       Impact factor: 9.461

Review 3.  Adenosine triphosphate-sensitive potassium channels in the cardiovascular system.

Authors:  C G Nichols; W J Lederer
Journal:  Am J Physiol       Date:  1991-12

Review 4.  Side effects associated with prostaglandin analog therapy.

Authors:  Albert Alm; Ian Grierson; M Bruce Shields
Journal:  Surv Ophthalmol       Date:  2008-11       Impact factor: 6.048

5.  Pharmacologic manipulation of conventional outflow facility in ex vivo mouse eyes.

Authors:  Alexandra Boussommier-Calleja; Jacques Bertrand; David F Woodward; C Ross Ethier; W Daniel Stamer; Darryl R Overby
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-08-24       Impact factor: 4.799

Review 6.  Functional roles of KATP channels in vascular smooth muscle.

Authors:  Joseph E Brayden
Journal:  Clin Exp Pharmacol Physiol       Date:  2002-04       Impact factor: 2.557

7.  The number of people with glaucoma worldwide in 2010 and 2020.

Authors:  H A Quigley; A T Broman
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

8.  Ocular hypotensive effects of anti-glaucoma agents in mice.

Authors:  Takahiro Akaishi; Noriko Odani-Kawabata; Naruhiro Ishida; Masatsugu Nakamura
Journal:  J Ocul Pharmacol Ther       Date:  2009-10       Impact factor: 2.671

9.  Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.

Authors:  Anders Heijl; M Cristina Leske; Bo Bengtsson; Leslie Hyman; Boel Bengtsson; Mohamed Hussein
Journal:  Arch Ophthalmol       Date:  2002-10

10.  Physiological and pathophysiological roles of ATP-sensitive K+ channels.

Authors:  Susumu Seino; Takashi Miki
Journal:  Prog Biophys Mol Biol       Date:  2003-02       Impact factor: 3.667

View more
  14 in total

1.  Analysis of Circadian Rhythm Gene Expression With Reference to Diurnal Pattern of Intraocular Pressure in Mice.

Authors:  Lauren A Dalvin; Michael P Fautsch
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-04       Impact factor: 4.799

2.  Diet Mimicking "Fast Food" Causes Structural Changes to the Retina Relevant to Age-Related Macular Degeneration.

Authors:  Gavin W Roddy; Robert H Rosa; Kimberly B Viker; Bradley H Holman; Cheryl R Hann; Anuradha Krishnan; Gregory J Gores; Sophie J Bakri; Michael P Fautsch
Journal:  Curr Eye Res       Date:  2019-12-02       Impact factor: 2.424

3.  Effect of Cromakalim Prodrug 1 (CKLP1) on Aqueous Humor Dynamics and Feasibility of Combination Therapy With Existing Ocular Hypotensive Agents.

Authors:  Uttio Roy Chowdhury; Tommy A Rinkoski; Cindy K Bahler; J Cameron Millar; Jacques A Bertrand; Bradley H Holman; Joseph M Sherwood; Darryl R Overby; Kristen L Stoltz; Peter I Dosa; Michael P Fautsch
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-11-01       Impact factor: 4.799

Review 4.  ATP sensitive potassium channel openers: A new class of ocular hypotensive agents.

Authors:  Uttio Roy Chowdhury; Peter I Dosa; Michael P Fautsch
Journal:  Exp Eye Res       Date:  2016-04-26       Impact factor: 3.467

5.  Analogs of the ATP-Sensitive Potassium (KATP) Channel Opener Cromakalim with in Vivo Ocular Hypotensive Activity.

Authors:  Uttio Roy Chowdhury; Kimberly B Viker; Kristen L Stoltz; Bradley H Holman; Michael P Fautsch; Peter I Dosa
Journal:  J Med Chem       Date:  2016-07-01       Impact factor: 7.446

6.  ATP-sensitive potassium (KATP) channel openers diazoxide and nicorandil lower intraocular pressure by activating the Erk1/2 signaling pathway.

Authors:  Uttio Roy Chowdhury; Cindy K Bahler; Bradley H Holman; Michael P Fautsch
Journal:  PLoS One       Date:  2017-06-08       Impact factor: 3.240

Review 7.  Novel Therapeutics in Glaucoma Management.

Authors:  Claudio Bucolo; Chiara Bianca Maria Platania; Filippo Drago; Vincenza Bonfiglio; Michele Reibaldi; Teresio Avitabile; Maurizio Uva
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

8.  Ocular Hypotensive Effects of the ATP-Sensitive Potassium Channel Opener Cromakalim in Human and Murine Experimental Model Systems.

Authors:  Uttio Roy Chowdhury; Cindy K Bahler; Bradley H Holman; Peter I Dosa; Michael P Fautsch
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240

9.  Effect of potassium channel openers in acute and chronic models of glaucoma.

Authors:  Shital S Panchal; Anita A Mehta; Devdas D Santani
Journal:  Taiwan J Ophthalmol       Date:  2016-06-20

10.  Association between potassium channel SNPs and essential hypertension in Xinjiang Kazak Chinese patients.

Authors:  Yuan-Yuan Han; Li-Jie Wang; Liang Zhang; Wen-Wen Zhang; Ke-Tao Ma; Li Li; Jun-Qiang Si
Journal:  Exp Ther Med       Date:  2017-07-09       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.